GSK said the U.S. Food and Drug Administration approved its Blujepa oral antibiotic for the treatment of female adults and children with uncomplicated urinary tract infections.
Blujepa is the first new type of oral antibiotic to treat UTIs to gain approval in more than 20 years. Its development was ...
The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, ...
Simufilam did not show a significant reduction in co-primary endpoints of cognitive or functional decline versus placebo in patients with mild-to-moderate Alzheimer's diseaseSimufilam continued to dem ...
The U.S. Food and Drug Administration has approved Blujepa (gepotidacin) for the treatment of uncomplicated urinary tract ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results